...
首页> 外文期刊>The American surgeon. >Management of acute cholecystitis in critically ill patients: contemporary role for cholecystostomy and subsequent cholecystectomy.
【24h】

Management of acute cholecystitis in critically ill patients: contemporary role for cholecystostomy and subsequent cholecystectomy.

机译:急性胆囊炎在危重病患者急性胆囊炎:胆囊术和随后的胆囊切除术的当代作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The diagnosis of acute cholecystitis in critically ill patients carries a high mortality rate. Although decompression and drainage of the gallbladder through a cholecystostomy tube may be used as a temporary treatment of acute cholecystitis in this population, there is still some debate about the management of the tube and the subsequent need for a cholecystectomy. This series evaluates the clinical course and outcomes of critically ill patients who underwent the insertion of cholecystostomy tubes for the initial treatment of acute cholecystitis. This is a retrospective review of critically ill patients admitted to the hospital intensive care unit who were diagnosed with acute cholecystitis and underwent a cholecystostomy tube as a temporary treatment for the disease. Patients were identified through the Greenville Hospital System electronic medical records coding database. Medical records were reviewed for demographic data, diagnoses, imaging, complications, and outcomes. From January 2002 through June 2008, 50 patients were identified for the study. The mean age was 72 +/- 11 years, and the majority (66%) were men. The following comorbidities were found: severe cardiovascular disease (40 patients), respiratory failure (30 patients), and multisystem organ dysfunction (30 patients). The mean intensive care unit length of stay (LOS) was 16 +/- 9 days, and the mean hospital LOS was 28 +/- 27 days. At 30 days, the morbidity associated with the cholecystostomy tube itself was 4 per cent, but overall in-hospital morbidity and mortality rates were 62 and 50 per cent, respectively. Of the 25 patients who survived longer than 30 days, 12 retained their cholecystostomy tubes until they underwent cholecystectomy (four open, seven laparoscopic). All of the remaining 13 patients had their cholecystostomy tubes removed, and eight developed recurrent cholecystitis. Of these patients with recurrent of cholecystitis, five had cholecystectomy or repeat cholecystostomy, but the remaining three patients died. Although this is a small patient population, these data suggest that, in critically ill patients, cholecystostomy tubes should remain in place until the patient is deemed medically suitable to undergo cholecystectomy. Removal of the cholecystostomy tube without subsequent cholecystectomy is associated with a high incidence of recurrent cholecystitis and devastating consequences.
机译:临床病患者急性胆囊炎的诊断患有高死亡率。虽然通过胆囊细胞术管的胆囊的减压和排出可以用作这种人群中急性胆囊炎的暂时治疗,但仍有一些关于管的管理和随后需要胆囊切除术的争论。该系列评估临床课程和临床课程和结果,患有胆囊囊肿术治疗急性胆囊炎的初始治疗。这是对患有急性胆囊炎的医院密集护理单元的批评性患者的回顾性审查,并经历了胆囊囊肿,作为疾病的暂时治疗。通过GreenVille医院系统电子医疗记录编码数据库确定患者。审查了医疗记录,用于人口统计数据,诊断,成像,并发症和结果。从2002年1月至2008年6月,确定了50名患者进行研究。平均年龄为72 +/- 11岁,大多数(66%)是男性。发现以下可血管性:严重的心血管疾病(40名患者),呼吸衰竭(30名患者)和多系统器官功能障碍(30名患者)。平均重症监护单位住院时间(LOS)为16 +/- 9天,平均医院洛杉矶为28 +/- 27天。在30天后,与胆囊囊肿本身有关的发病率为4%,但分别总医院的发病率和死亡率分别为62%和50%。在超过30天的25名患者中,12患者保留了他们的胆囊囊肿管,直到它们接受了胆囊切除术(四个开放,七个腹腔镜)。剩下的所有13名患者都被移除了胆囊囊肿术,并且八个发达的经常性胆囊炎。在这些胆囊炎的复发患者中,五个胆囊切除术或重复胆囊囊肿,但其余的三名患者死亡。虽然这是一个小患者人口,但这些数据表明,在危重病患者中,胆囊囊肿管应保持在患者被认为是适合经历胆囊切除术的患者。除了随后的胆囊切除术的胆囊过敏管的去除与复发性胆囊炎的高发病率和破坏性后果有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号